The experts group stats & facts
Experts
Countries
Publications
Recent updates
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
Authors: Antonio Simone Laganà, Paola Rossetti, Fabrizio Sapia, Benito Chiofalo, Massimo Buscema, Gaetano Valenti, Agnese Maria Chiara Rapisarda, Salvatore Giovanni Vitale
Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy
Authors: Pietro Cavalli and Elena Ronda
Combining treatment with myo-inositol and D -chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients
Authors: Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri
Physiological Role and Clinical Utility of Inositols in Polycystic Ovary Syndrome
Authors: Arturo Bevilacqua, Mariano Bizzarri
Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
Authors: Mariano Bizzarri, Simona Dinicola, Arturo Bevilacqua, and Alessandra Cucina
Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome
Authors: Anshu Gupta, Daniela Jakubowicz, and John E. Nestler
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
Authors: Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas, and Fabio Facchinetti
Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
Authors: Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti, and Marialuisa Appetecchia
Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator During Weight Loss in Obese Women With and Without Polycystic Ovary Syndrome
Authors: Kai I Cheang, Sakita N Sistrun, Kelley S Morel, John E Nestler
Myo-Inositol Safety in Pregnancy: From Preimplantation Development to Newborn Animals
Authors: Nilay Kuşcu, Mariano Bizzarri, and Arturo Bevilacqua